Organization
Pharmacology Discovery Services Taiwan, Ltd.
9 abstracts
Abstract
Depletion of histone H3K27 demethylase exerts anti-tumor activity as a monotherapy and in combination therapy with ceralasertib in non-small cell lung carcinoma.Org: Pharmacology Discovery Services Taiwan, Ltd., partner lab of Eurofins, Pharmacology Discovery Services Ltd., Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taiwan International Graduate Program in Molecular Medicine, Institute of Biomedical Sciences, Academia Sinica and National Yang Ming Chiao Tung University,
Abstract
Identification of a novel squalene epoxidase function in breast cancer brain metastasis.Org: Pharmacology Discovery Services Taiwan, Ltd., partner lab of Eurofins, Pharmacology Discovery Services Ltd., Taiwan, New Taipei City, Taiwan, Institute of Biomedical Sciences, Academia Sinica, Program for Cancer Biology and Drug Discovery, China Medical University, Taichung, Taiwan,
Abstract
ANTI-INFLAMMATORY DRUGS SPARRING AS A REFLECT OF INFLIXIMAB THERAPY EFFICACY IN REFRACTORY SPONDYLOARTHROPATHIESOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Pharmacology Discovery Services Taiwan, Ltd., Pellegrin, Bordeaux University Hospital, France,
Abstract
A SELECTIVE ESTROGEN RECEPTOR ALPHA AGONIST (ORG 37663) SUPPRESSES INFLAMMATION AND ARTHRITIS IN MOUSE MODELSOrg: Pharmacology Discovery Services Taiwan, Ltd., Target Discovery, Organon N.V., Department of Rheumatology, Radboud University Nijmegen Medical Center,
Abstract
ARRY-162, A SELECTIVE, POTENT MEK1/2 INHIBITOR, SIGNIFICANTLY REDUCES EX VIVO IL-1 BETA AND TNF ALPHA; PRODUCTION IN NORMAL SUBJECTSOrg: Chemistry, Bar Ilan University, Ramat Gan, Israel, Biology Department, Bashkir State Medical University, Pharmacology Discovery Services Taiwan, Ltd., Translational Research Institute and Dermatology Institute, Drug Metabolism,
Abstract
ARRY-797, A SELECTIVE, POTENT INHIBITOR OF P38, PROMOTES DISEASE NORMALIZATION IN ANIMAL MODELS OF RHEUMATOID ARTHRITIS AND SIGNIFICANTLY REDUCES EX VIVO IL-1 BETA, PGE2 AND TNF- ALPHA PRODUCTION IN NORMAL HUMAN SUBJECTSOrg: Pharmacology Discovery Services Taiwan, Ltd., Biology Department, Bashkir State Medical University, Clinical Trials Unit, Institute of Precision Medicine, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, Chemistry, Bar Ilan University, Ramat Gan, Israel, Drug Metabolism,
Abstract
BIODISTRIBUTION AND KINETICS OF RADIOLABELED INFLIXIMAB IN RESPONDERS AND NON-RESPONDERS TO TREATMENT OF RHEUMATOID ARTHRITISOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Nuclear Medicine and PET Center Department, Otolaryngology and Head and Neck Surgery, VU University Medical Center, Sanquin Research, Immunoglobulin Research, Amsterdam, Netherlands,
Abstract
BCX4208, A NOVEL URATE-LOWERING THERAPY, WAS GENERALLY SAFE AND WELL TOLERATED IN TWO 3-WEEK STUDIES IN GOUT SUBJECTS Org: Pharmacovigilance, BioCryst Pharmaceuticals, Inc., Durham, NC, Biostatistics, PharPoint Research Inc., Chapel Hill, NC, Pharmacology Discovery Services Taiwan, Ltd., Clinical Development, BioCryst Pharmaceuticals, Inc., Durham, NC, United States,
Abstract
BEHÇET'S DISEASE: IS THERE INSULIN RESISTANCE?Org: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Endocrinology and Metabolism Institute, Pharmacology Discovery Services Taiwan, Ltd., Cumhuriyet University Faculty of Medicine, Physical Medicine and Rehabilitation, Marmara University Medical School, Istanbul,